FASEB SRC on Liver Biology: Fundamental Mechanisms & Translational Application

FASEB SRC 肝脏生物学:基本机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): The current application seeks partial support for the Federation of American Societies for Experimental Biology (FASEB) summer research conference on "Liver Biology: Fundamental Mechanisms & Translational Applications". For the past 20 years, this meeting has been held biennially and is now recognized as the world's premier conference covering all aspects of basic science research involving the liver. The conference will be held from July 29-August 3, 2012 in Snowmass, Colorado. The main goals of the conference are to i) integrate the research advances offered by disparate areas of liver biology in order to foster new collaborative projects on both national and international scale, ii) encourage junior and early stage investigators, women and minority scientists to pursue liver research to ensure that the study of hepatic disease and biology remains vigorous and iii) accelerate translation of fundamental advances in liver biology into novel clinical treatments through the interactions of basic and clinical researchers. These goals will be achieved through specific programmatic strategies. The program is divided into nine major sessions and includes presentations from thirty-nine invited speakers. In addition, these sessions will accommodate multiple short 'late-breaking' talks that will be chosen to represent the most significant and timey research advances in liver research. Preference will be given to junior, minority and women investigators. The program also provides two poster sessions for one-on-one dialogue and several additional opportunities for informal, yet intimate scientific exchange among speakers and attendees throughout the stay and a newly added "meet-the-experts session that will be geared towards and will allow younger investigators an additional opportunity to network with the more established and senior investigators in the liver field. Specific session topics include liver differentiation and organogenesis, Regulation of hepatobiliary gene expression in health and disease, Liver growth and regeneration, Liver metabolism in health and disease, Angiogenesis, Injury and Hepatic fibrosis, Liver cancer, Liver stem cells: Implications in regenerative medicine and development and Hepatocyte, stem cell transplantation and tissue engineering. This conference advances the goals of the NIH action plan for liver disease research in a format that truly integrates multiple disciplines, clearly emphasizing the novelty and significance of the FASEB summer research conference. Thus, the program incorporates the most relevant and timely topics in basic and applied aspects of liver health and disease to promote scientific exchange, dissemination, education and collaboration and translation. PUBLIC HEALTH RELEVANCE: The FASEB summer research conference on "Liver Biology: Fundamental Mechanisms & Translational Applications" is the premier international conference on basic and translational research in liver biology. The goal of the conference is to broaden the attendees' understanding of liver biology in order to advance treatment and diagnosis of liver diseases.
描述(由申请人提供):当前申请寻求美国实验生物学会联合会(FASEB)夏季研究会议“肝脏生物学:基本机制和转化应用”的部分支持。过去20年来,该会议每两年举行一次,现已被公认为涵盖肝脏基础科学研究各个方面的世界顶级会议。会议将于2012年7月29日至8月3日在科罗拉多州斯诺马斯举行。会议的主要目标是:i) 整合肝脏生物学不同领域的研究进展,以促进国内和国际范围内的新合作项目,ii) 鼓励初级和早期研究人员、女性和少数族裔科学家进行肝脏研究,以确保肝脏疾病和生物学研究保持活力,以及 iii) 通过基础研究人员和临床研究人员的互动,加速将肝脏生物学的基本进展转化为新型临床治疗方法。这些目标将通过具体的计划战略来实现。该计划分为九个主要会议,包括三十九位受邀演讲者的演讲。此外,这些会议将容纳多个简短的“最新”演讲,这些演讲将被选择代表肝脏研究中最重要和最及时的研究进展。将优先考虑初级、少数族裔和女性调查员。该计划还提供了两次一对一对话的海报会议,以及在整个停留期间演讲者和与会者之间非正式但亲密的科学交流的一些额外机会,以及新增加的“与专家会面”会议,该会议将面向并将为年轻的研究人员提供了与肝脏领域更成熟和资深的研究人员建立联系的额外机会,具体会议主题包括肝脏分化和器官发生、健康和疾病中肝胆基因表达的调节、肝脏生长和再生、健康和疾病中的肝脏代谢。 ,血管生成、损伤和肝纤维化、肝癌、肝干细胞:对再生医学和发育以及肝细胞、干细胞移植和组织工程的影响本次会议以真正整合的形式推进了 NIH 肝病研究行动计划的目标。多学科交叉,明确强调了FASEB夏季研究会议的新颖性和意义。因此,该计划纳入了肝脏健康和疾病的基础和应用方面最相关和最及时的主题,以促进科学交流、传播、教育、合作和翻译。 公共健康相关性:FASEB 夏季研究会议“肝脏生物学:基本机制和转化应用”是肝脏生物学基础和转化研究的首要国际会议。会议的目标是扩大与会者对肝脏生物学的了解,以推进肝脏疾病的治疗和诊断。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda E GREENBAUM其他文献

Linda E GREENBAUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda E GREENBAUM', 18)}}的其他基金

Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8265850
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8048131
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    7863457
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8480398
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8434170
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
  • 批准号:
    7848538
  • 财政年份:
    2009
  • 资助金额:
    $ 1.5万
  • 项目类别:
Transcriptional Control in Hepatocyte Proliferation
肝细胞增殖的转录控制
  • 批准号:
    6524459
  • 财政年份:
    2001
  • 资助金额:
    $ 1.5万
  • 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
  • 批准号:
    7589776
  • 财政年份:
    2001
  • 资助金额:
    $ 1.5万
  • 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
  • 批准号:
    7800423
  • 财政年份:
    2001
  • 资助金额:
    $ 1.5万
  • 项目类别:
Transcriptional Control in Hepatocyte Proliferation
肝细胞增殖的转录控制
  • 批准号:
    6400608
  • 财政年份:
    2001
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似国自然基金

秦岭生态效益转化与区域绿色发展模式
  • 批准号:
    72349001
  • 批准年份:
    2023
  • 资助金额:
    200 万元
  • 项目类别:
    专项基金项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
  • 批准号:
    72364037
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目
农产品区域公用品牌地方政府干预机制与政策优化研究
  • 批准号:
    72373068
  • 批准年份:
    2023
  • 资助金额:
    41 万元
  • 项目类别:
    面上项目
政府数据开放与资本跨区域流动:影响机理与经济后果
  • 批准号:
    72302091
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
  • 批准号:
    10558119
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
The Meharry Cancer Summer Research Program (SuRP)
梅哈里癌症夏季研究计划 (SuRP)
  • 批准号:
    10715291
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
  • 批准号:
    10606212
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
2023 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2023肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
  • 批准号:
    10606049
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Methods in Clinical Cancer Research Workshop
临床癌症研究方法研讨会
  • 批准号:
    10721362
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了